Volume 1, Issue 12: Therapeutic Advances in Type 2 Diabetes Treatment

e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 1, Issue 12)

 

Target Audience

Nurses and health care professionals involved in the care of patients with diabetes.

 

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to: 

  • Discuss the safety implications of recent clinical trials with DPP-4 inhibitors.
  • Summarize the glycemic and non-glycemic effects of SGLT-2 inhibitors.
  • Describe the recent data on the use of SGLT-2 inhibitors in dual and triple therapy, as well as in combination with insulin.
  • Summarize the benefits of longer-acting insulin formulations.

 

Additional information
Contact email: 
ijhn@jhmi.edu
Course summary
Available credit: 
  • 0.50 ANCC
  • 0.50 Attendance
Registration opens: 
05/28/2015
Registration closes: 
05/27/2017
Cost:
$0.00
Nestoras Mathioudakis, MD
Assistant Professor of Medicine
Division of Endocrinology, Diabetes, & Metabolism
Associate Director, Inpatient Diabetes Management Service Program
Johns Hopkins University School of Medicine
Baltimore, Maryland
 
Om Ganda, MD
Associate Clinical Professor of Medicine
Senior Physician and Director, Lipid Clinic
Chair, Clinical Oversight Committee
Joslin Diabetes Center
Boston, Massachusetts
 

Available Credit

  • 0.50 ANCC
  • 0.50 Attendance

Price

Cost:
$0.00
Please login or register to take this course.